HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Oct. 26, 2017 (HealthDay News) -- Long-acting reversible contraceptives (LARC), including implants and intrauterine devices (IUDs), are a safe and effective contraception option for many women, according to a practice bulletin published online Oct. 24 in Obstetrics & Gynecology.
Eve Espey, M.D., M.P.H., and Lisa Hofler, M.D., M.P.H., M.B.A., from the University of New Mexico School of Medicine, developed the practice bulletin in collaboration with the American College of Obstetricians and Gynecologists' Committee on Practice Bulletins -- Gynecology and the Long-Acting Reversible Contraception Work Group. They discussed data on the safety of LARC, which are the most effective reversible contraceptive methods.
The authors note that LARC do not require an ongoing effort on the part of the patient and are associated with rapid return of fertility after the device is removed. Insertion of an IUD should be offered routinely as a safe and effective contraceptive option after first-trimester uterine aspiration. Insertion of the implant should be offered routinely on the same day as first- or second-trimester induced or spontaneous abortion. Before IUD insertion, routine antibiotic prophylaxis is not recommended. These recommendations are based on good and consistent scientific evidence. Based on limited or inconsistent evidence, IUDs and contraceptive implants should be offered routinely for nulliparous women and adolescents; insertion may occur at any time during the menstrual cycle when pregnancy can be excluded; insertion immediately after completion of first-trimester medication-induced abortion should be offered routinely; and immediate postpartum insertion should be offered routinely for postpartum contraception regardless of breastfeeding status.
"Counseling will help women to align their contraceptive choice with other health care priorities, whether that's preventing pregnancy during adolescence or making a plan for contraceptive use following pregnancy," Espey said in a statement.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 29, 2022